A somatic guanine-to-thymine substitution (c.1849G > T) located in the terminal part of JAK2 exon 14 was observed in MPN patients, resulting in changes in amino acids (V617F), altering the pseudokinase domain structure. This evidence concerns the gene JAK2 and myeloproliferative neoplasm.